Emmaus Life Sciences (EMMA) SEC Filings & 10K Form $0.04 +0.00 (+12.50%) As of 02/21/2025 01:23 PM Eastern Add Compare Share Share SEC Filings Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Recent Emmaus Life Sciences SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView02/04/202510:00 AMEmmaus Life Sciences (Subject)Lim Seah H. (Filed by)Form SCHEDULE 13G/A10/09/20241:35 PMEmmaus Life Sciences (Issuer)Kuwahara Jon (Reporting)Form 3Initial statement of beneficial ownership of securities 10/04/20244:23 PMEmmaus Life Sciences (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 09/18/202410:40 AMEmmaus Life Sciences (Issuer)Lim Seah H. (Reporting)Form 4Statement of changes in beneficial ownership of securities 09/10/20244:01 PMEmmaus Life Sciences (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 09/10/202412:15 PMEmmaus Life Sciences (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 09/10/202412:26 PMEmmaus Life Sciences (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 08/15/20243:30 PMEmmaus Life Sciences (Filer)Form NT 10-Q07/17/20244:28 PMEmmaus Life Sciences (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/03/20248:40 AMEmmaus Life Sciences (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/28/20244:23 PMEmmaus Life Sciences (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/01/20244:27 PMEmmaus Life Sciences (Filer)Form NT 10-K02/29/20245:11 PMEmmaus Life Sciences (Issuer)LEE WILLIS C (Reporting)Form 4Statement of changes in beneficial ownership of securities 02/26/20247:00 AMEmmaus Life Sciences (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies PharmaCyte Biotech SEC Filings Inhibitor Therapeutics SEC Filings Chromocell Therapeutics SEC Filings BetterLife Pharma SEC Filings Talphera SEC Filings Kiora Pharmaceuticals SEC Filings Klotho Neurosciences SEC Filings Jaguar Health SEC Filings Brainstorm Cell Therapeutics SEC Filings PHAXIAM Therapeutics SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (OTCMKTS:EMMA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emmaus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Emmaus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EMMA Stock Alerts